DNMT3A and pulmonary arterial hypertension: We are intrigued by the observation that the loss of TET2 function, which would be predicted to increase gene methylation, results in similar endpoints (development of inflammation and PAH) as those that occur with loss-of-function mutations of DNMT3A, which might be expected to reduce gene methylation.